Ignite Creation Date:
2025-12-24 @ 1:32 PM
Ignite Modification Date:
2026-01-03 @ 3:26 AM
Study NCT ID:
NCT04767295
Status:
UNKNOWN
Last Update Posted:
2021-02-23
First Post:
2021-01-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Camrelizumab Combined With Chemotherapy as Neoadjuvant Therapy in Adcanced Esophageal Squamous Cell Carcinoma (ESCC)
Sponsor:
Hunan Cancer Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HNCH-ESCC-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |